Company intelligence / Profile preview

Cholestech

Hayward, California, United States

Ownership: Private
Development stage: Other

Overview

Cholestech Corporation was a medical technology company specializing in point-of-care diagnostic products for the management of cholesterol and related lipids. Its primary product, the Cholestech LDX System, enabled healthcare providers to obtain a complete lipid profile and glucose measurement from a single fingerstick of blood in approximately five minutes. This rapid turnaround facilitated immediate clinical decisions regarding cardiovascular disease and diabetes management. The company was acquired by Inverness Medical Innovations in 2007, which subsequently became Alere and was later acquired by Abbott.

Therapeutic areas: EndocrinologyCardiovascularMetabolic Disorders
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Cholestech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholestech.

Explore the full profile